Wird geladen...
MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
BACKGROUND: MYO18B has been identified as a novel tumor suppressor gene in several cancers. However, its specific roles in the progression of hepatocellular carcinoma (HCC) has not been well defined. METHODS: We firstly identified the expression and prognostic values of MYO18B in HCC using TCGA coho...
Gespeichert in:
| Veröffentlicht in: | Diagn Pathol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6215340/ https://ncbi.nlm.nih.gov/pubmed/30390677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-018-0763-3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|